Acute myeloid leukemia with 11q23-abnormality in remission

This code signifies a specific subtype of acute myeloid leukemia (AML) characterized by a genetic abnormality involving the 11q23 chromosomal region, which is currently in a state of remission. This means the patient has previously been diagnosed with this aggressive blood cancer, and treatment has successfully reduced or eliminated the signs and symptoms of the disease.

Apply this code when documentation clearly indicates a patient with a history of acute myeloid leukemia with the 11q23-abnormality, and their current disease status is confirmed as being in remission. This is typically supported by bone marrow biopsy results, peripheral blood counts, and genetic testing confirming the 11q23 aberration.

• Ensure documentation explicitly states "in remission" for AML with the 11q23-abnormality; do not assume remission.
• Distinguish from active disease (C92.60) or AML in relapse.
• Always sequence this code after any codes for current treatment or complications related to the patient's history of AML.